United States Biospecimen Procurement Market Size, Trends and Companies

The US biospecimen procurement market size is calculated at USD 29.78 million in 2025, grew to USD 32.22 million in 2026, and is projected to reach around USD 65.49 million by 2035. The market is expanding at a CAGR of 8.2% between 2026 and 2035.

Key Takeaways

• The global biospecimen procurement market is expected to see growth from USD 98.71 million in 2026 to USD 207.40 million by 2035, expanding at a CAGR of 8.60%.
• North America dominated the global biospecimen procurement market share by 42% in 2025.
• Asia Pacific is expected to be the fastest-growing by 10.1% CAGR during the forecast period.
• By therapeutic area type, the oncological disorders segment dominated the market in 2025.
• By type of biospecimen for oncological studies, the FFPE segment dominated the market in 2025.
• By type of biospecimen for non-oncological studies, the blood product segment dominated the global biospecimen procurement market in 2025.

Market Overview

For ideal evaluation of proteome, genome, and transcriptome, the preserved frozen biospecimens are often used. The process of obtaining biospecimens such as fresh tissue samples, whole blood samples, FFPE tissue blocks, etc., for life science research and development studies is known as biospecimen procurement. Biospecimen procurement consists of various steps, like identification of biospecimen providers containing the sample of interest, ordering the samples, monitoring the sample collected, and shipping the samples. The biospecimen procurement can also be carried out by setting up the studies with clinicians that use hospital or university biobanks or by using biospecimens from commercial companies.

Top Companies in the Biospecimen Procurement Market

• Creative Bioarray
• BioChain Institute
• Discovery Life Sciences
• BioIVT
• National BioService
• PrecisionMed
• Infinity BiologiX
• Medicove
• REPROCELL
• Precision for Medicine

Segments Covered in the Report

By Type

• Oncological Studies
  
  • Tissue-Based Biospecimens
    
    • Formalin-Fixed Paraffin-Embedded (FFPE)
    • Frozen Tissue
  • Blood-Based Biospecimens
    
    • Whole Blood
    • Plasma / Serum
  • Other Biospecimens
• Non-Oncological Studies
  
  • Tissue-Based Biospecimens
    
    • Formalin-Fixed Paraffin-Embedded (FFPE)
    • Frozen Tissue
  • Blood-Based Biospecimens
    
    • Whole Blood
    • Plasma / Serum
  • Other Biospecimens